UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 94,768 Shares of Cardinal Health, Inc. (NYSE:CAH)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Cardinal Health, Inc. (NYSE:CAH) by 4.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 2,321,797 shares of the company’s stock after buying an additional 94,768 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.96% of Cardinal Health worth $274,599,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of CAH. Cyrus J. Lawrence LLC acquired a new position in shares of Cardinal Health during the fourth quarter valued at $26,000. Promus Capital LLC acquired a new position in Cardinal Health during the 4th quarter valued at about $30,000. Bellwether Advisors LLC bought a new position in shares of Cardinal Health in the 4th quarter valued at about $32,000. Lee Danner & Bass Inc. bought a new position in shares of Cardinal Health in the 4th quarter valued at about $35,000. Finally, Itau Unibanco Holding S.A. acquired a new stake in shares of Cardinal Health during the 4th quarter worth approximately $36,000. 87.17% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

CAH has been the topic of a number of recent research reports. StockNews.com raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Monday, May 5th. Mizuho raised their price target on Cardinal Health from $142.00 to $150.00 and gave the stock an “outperform” rating in a research report on Monday, March 31st. Citigroup reiterated a “neutral” rating on shares of Cardinal Health in a report on Thursday, May 1st. Argus set a $148.00 target price on Cardinal Health in a research note on Tuesday, February 4th. Finally, Bank of America boosted their target price on Cardinal Health from $150.00 to $155.00 and gave the stock a “buy” rating in a research report on Friday, April 11th. Four research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $146.43.

Cardinal Health Stock Performance

Shares of CAH opened at $153.27 on Thursday. The stock has a 50 day simple moving average of $138.70 and a 200 day simple moving average of $128.54. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $156.44. The firm has a market capitalization of $36.58 billion, a PE ratio of 28.59, a P/E/G ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, beating analysts’ consensus estimates of $2.15 by $0.20. The firm had revenue of $54.88 billion for the quarter, compared to analyst estimates of $55.33 billion. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The business’s revenue was up .0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.08 earnings per share. Equities research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a $0.5107 dividend. The ex-dividend date of this dividend is Tuesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.04 dividend on an annualized basis and a yield of 1.33%. Cardinal Health’s dividend payout ratio is presently 31.83%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.